SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-018929
Filing Date
2017-11-09
Accepted
2017-11-09 17:16:36
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20170930_10q.htm 10-Q 1360951
2 EXHIBIT 31.1 ex_97235.htm EX-31.1 14450
3 EXHIBIT 31.2 ex_97236.htm EX-31.2 14527
4 EXHIBIT 32.1 ex_97237.htm EX-32.1 6996
5 EXHIBIT 32.2 ex_97238.htm EX-32.2 7263
  Complete submission text file 0001437749-17-018929.txt   4216841

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20170930.xml EX-101.INS 672694
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20170930.xsd EX-101.SCH 36739
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20170930_cal.xml EX-101.CAL 28589
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20170930_def.xml EX-101.DEF 291223
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20170930_lab.xml EX-101.LAB 222998
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20170930_pre.xml EX-101.PRE 296500
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 171191910
SIC: 2834 Pharmaceutical Preparations